<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="family-medicine" lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher">JOHS</journal-id>
      <journal-id journal-id-type="nlm-ta">Journ of Health Scien</journal-id>
      <journal-title-group>
        <journal-title>Journal of HealthCare Sciences</journal-title>
        <abbrev-journal-title abbrev-type="pubmed">Journ of Health Scien</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2231-2196</issn>
      <issn pub-type="opub">0975-5241</issn>
      <publisher>
        <publisher-name>Radiance Research Academy</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">506</article-id>
      <article-id pub-id-type="doi">http://dx.doi.org/10.52533/JOHS.2026.60111</article-id>
      <article-id pub-id-type="doi-url"/>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Family Medicine</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Emerging Non-Opioid Analgesics for Acute and Postoperative Pain Management&#13;
</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Sulimani</surname>
            <given-names>Rami Jamal</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Althobaiti</surname>
            <given-names>Renas Hani</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Almurayyi</surname>
            <given-names>Ethar Mohammed</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Arishi</surname>
            <given-names>Ghazi Ibrahim</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alzawawi</surname>
            <given-names>Abdulelah Ali</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Almatrafi</surname>
            <given-names>Khaled Nasser</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alnahi</surname>
            <given-names>Saad Abdullah</given-names>
          </name>
        </contrib>
      </contrib-group>
      <pub-date pub-type="ppub">
        <day>25</day>
        <month>01</month>
        <year>2026</year>
      </pub-date>
      <volume>6</volume>
      <issue>1</issue>
      <fpage>82</fpage>
      <lpage>87</lpage>
      <permissions>
        <copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement>
        <copyright-year>2009</copyright-year>
        <license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Effective pain control remains a central goal in acute and postoperative care, yet reliance on opioids continues to pose significant clinical and public health concerns. Opioids, while potent, carry well-documented risks including dependence, respiratory depression, and delayed recovery. In response, recent advances in pharmacology have introduced several non-opioid analgesics that offer alternative or complementary pathways to manage pain. These include classes such as cannabinoid receptor modulators, sodium and calcium channel blockers, NMDA receptor antagonists, monoclonal antibodies targeting nerve growth factor, and TRP channel modulators. Each class interacts with distinct biological targets involved in nociception, offering analgesic effects through both central and peripheral mechanisms. Non-opioid therapies are now being integrated into multimodal pain management protocols, where their combination with other agents helps reduce total opioid use while maintaining effective pain control. Applications span a variety of surgical procedures and acute care scenarios, with growing evidence supporting their role in lowering pain scores, improving recovery, and preventing transition to chronic pain. However, challenges remain, including variability in patient response, safety concerns, and limitations in translating preclinical success into clinical outcomes. Current research is exploring novel drug delivery systems, personalized pain management strategies, and improved trial methodologies to enhance efficacy and minimize adverse effects. As innovation in analgesic science continues, the role of non-opioid medications is expected to expand, shaping a future of pain management that is safer, more targeted, and responsive to individual patient needs.&#13;
</p>
      </abstract>
      <kwd-group>
        <kwd>non-opioid analgesics</kwd>
        <kwd> acute pain</kwd>
        <kwd> postoperative pain</kwd>
        <kwd> multimodal analgesia</kwd>
        <kwd> pain management</kwd>
      </kwd-group>
    </article-meta>
  </front>
</article>